T 2430/17 (Thrombocythemia/GALENICUM HEALTH) of 28.04.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T243017.20210428
- Date of decision
- 28 April 2021
- Case number
- T 2430/17
- Petition for review of
- -
- Application number
- 11710202.0
- IPC class
- A61K 31/517A61K 9/20
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
- Applicant name
- AOP Orphan Pharmaceuticals AG
- Opponent name
- Galenicum Health S.L.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(3)European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(1)(a)Rules of procedure of the Boards of Appeal Art 12(2)
- Keywords
- Sufficiency of disclosure - main request (no)
Inventive step - main request (no)
Amendments - broadening of claim (yes)
Basis of proceedings - decision under appeal - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.